- Denosumab for treatment of hypercalcemia of malignancy. The Journal of clinical endocrinology and metabolism. 2014 Academic Article GET IT
- Response. Journal of the National Cancer Institute. 2014 Information Resource GET IT
- Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. Journal of the National Cancer Institute. 2013 Academic Article GET IT
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 19